Handelsavisen
prelaunch
Companies Healthcare JUSH.CD
JU
JUSH.CD Healthcare Facilities & Services

Jushi Holdings Inc

$0,60
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
6,9 %
ROE
82,7 %
Net margin
-28,0 %
Debt / equity
-12,09
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Jushi Holdings Inc is a vertically integrated cannabis company that operates in the cultivation, processing, and retail of cannabis products, primarily in the United States.

Business. Jushi Holdings Inc (JUSH.CD) operates in the Healthcare Facilities & Services industry, primarily engaged in pharmaceutical activities. The company generates revenue through service-based models within the broader Healthcare Services & Equipment sector. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the business is described at the industry level without geographic or segmental breakdowns.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
BUY5 analysts
4 buy1 hold0 sell
Avg 12m price target1,48

Analyst recommendations

5 analysts · consensus Buy
Buy4
Hold1
Sell0
12-month price target
1,48
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
5 analysts · indicative
Ownership
not yet wired
Profitability
82,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning JUSH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to JUSH.CD. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Jushi Holdings Inc (JUSH.CD) operates in the Healthcare Facilities & Services industry, primarily engaged in pharmaceutical activities. The company generates revenue through service-based models within the broader Healthcare Services & Equipment sector. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the business is described at the industry level without geographic or segmental breakdowns.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    Jushi Holdings Inc has a negative equity position of -$22.2 million and a debt-to-equity ratio of -12.09, indicating a highly leveraged capital structure with negative net worth. The company maintains $25.3 million in cash and equivalents, but this is significantly less than its $268.5 million in long-term debt, resulting in a liquidity risk rating of medium. The current ratio of 0.51 further underscores the company's limited ability to meet short-term obligations with current assets.

    Profitability metrics show mixed results. The company reported a gross profit of $32.3 million on $65.5 million in revenue, yielding a gross margin of 49.3%. However, net income was -$18.4 million, driven by a negative return on assets of -4.01% and a return on equity of 82.7% due to the negative equity base. These figures fall below the industry median for profitability, indicating operational inefficiencies or cost overruns relative to peers.

    The company's revenue is concentrated in the United States, with no disclosed international operations. Jushi operates through cultivation, processing, and retail segments, but the input data does not provide segment-specific revenue breakdowns. This lack of transparency limits the ability to assess geographic or product diversification.

    Looking ahead, the company is expected to face continued financial pressure. The current fiscal year outlook indicates a negative net income trajectory, with no clear path to profitability in the next fiscal year. The capital expenditure of -$1.1 million suggests minimal investment in growth, which may hinder long-term revenue expansion.

    Risk factors include a high debt load, negative equity, and limited liquidity. The risk assessment flags a negative net cash position after subtracting total debt, which could lead to refinancing challenges. The dilution risk is currently rated as low, but the company's negative equity and potential need for capital raises could increase dilution pressure in the future.

    Recent events include the release of Q4 financial results, which showed a net loss of $18.4 million. Analysts have issued a mean price target of $1.48, with a median of $1.70, but no strong buy recommendations. The company has not disclosed any major strategic initiatives or product launches in the latest filings.

    Key takeaways
    • Jushi Holdings Inc has a highly leveraged capital structure with negative equity and a debt-to-equity ratio of -12.09.
    • The company reported a net loss of $18.4 million despite a 49.3% gross margin, indicating operational inefficiencies.
    • Liquidity is constrained, with a current ratio of 0.51 and $25.3 million in cash against $268.5 million in long-term debt.
    • Analysts have issued a mean price target of $1.48, but no strong buy recommendations, reflecting cautious sentiment.
    • The company's financial outlook remains negative, with no clear path to profitability in the near term.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Analysts project 147% upside to a mean price target of $1.48, signaling strong institutional confidence in future valuation recovery.

    Operating income turned positive in FY2025, reaching $8.8 million, demonstrating improved operational efficiency compared to previous years' losses.

    Gross profit expanded to $118.3 million in FY2025, indicating resilient top-line performance despite broader net income volatility.

    Revenue grew at a 5.9% CAGR over four years, showing consistent top-line expansion despite recent quarterly fluctuations.

    BEAR CASE · 1

    The company carries a high credit risk flag, compounded by a negative book value of $22.2 million.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights

    Revenue $68.3M, +3,8% YoY; Operating income +142,5% YoY.

    Revenue$68.3M+3,8 % YoY
    Operating income$782.0k+142,5 % YoY
    Net income-$15.6M−24,8 % YoY
    Free cash flow-$11.6M−71,6 % YoY
    EPS
    Operating cash flow$17.7M−17,8 % YoY
    Financials
    Income statement
    Revenue$68.3M
    Gross profit$28.6M
    Operating income$782.0k
    Net income-$15.6M
    Margins
    Gross margin41.9%
    Operating margin1.1%
    Net margin-22.8%
    FCF margin-16.9%
    Balance sheet
    Total assets$422.3M
    Total liabilities$537.7M
    Total equity-$115.3M
    Cash & equivalents$24.0M
    Long-term debt$270.5M
    Cash flow
    Operating cash flow$17.7M
    CapEx-$17.3M
    Free cash flow-$11.6M
    SBC
    P&L flow · revenue → net income
    Revenue $68.3MOperating costs $67.6MTax $16.3MNet income $15.6M
    Highlights
    • Revenue $68.3M, +3,8% YoY
    • Operating income +142,5% YoY
    • Net income −24,8% YoY
    • Free cash flow −71,6% YoY
    • Net margin -22.8%

    Valuation TTM

    Market price
    $0,60
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    -$22.2M
    Net cash
    -$243.2M
    Current ratio
    0.5
    Debt / equity
    -12.1
    ROA
    -4.0%
    ROE
    82.7%
    Cash conversion
    -35.0%
    CapEx / revenue
    -1.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,19
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    5
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-10 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate-0,19
    Revenueno estimateno estimate274,4M USD
    Operating incomeno estimateno estimate21,5M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy0
    Buy4
    Hold1
    Sell0
    Strong sell0
    12-month price target$1,48 · Median $1,70
    Low $0,75High $2,00
    Operating income · consensus21,5M USD
    EPS surprise
    −86,7 %
    reported vs consensus · miss
    Revenue surprise
    −4,2 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$0,75
    Mean$1,48
    Median$1,70
    High$2,00
    Spot$0,60
    +147.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin6,9 %Below median
    Net Margin-28,0 %Bottom quartile
    ROE82,7 %Best in class
    Capex / Rev-1,7 %Above P75
    D/E-12,09Best in class
    Cash Conv-0,35Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Jushi Holdings Inc Market data — financials · 2026-05-28
    • Jushi Holdings Inc Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    JUSH.CDCanonical
    — · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-03-31 16:00 UTCEARNINGSQuarterly results — Q4 2025 Revenue USD 68.3M · Net USD -15.6M
    2026-03-31 16:00 UTCEARNINGSAnnual results — FY 2026 Revenue USD 262.9M · Net USD -68.6M
    2025-11-04 16:00 UTCEARNINGSQuarterly results — Q3 2025 Revenue USD 65.7M · Net USD -23.7M
    2025-08-05 16:00 UTCEARNINGSQuarterly results — Q2 2025 Revenue USD 65.0M · Net USD -12.3M
    2025-05-08 16:00 UTCEARNINGSQuarterly results — Q1 2025 Revenue USD 63.8M · Net USD -17.0M
    2025-03-06 16:05 UTCEARNINGSQuarterly results — Q4 2024 Revenue USD 65.9M · Net USD -12.5M
    2025-03-06 16:05 UTCEARNINGSAnnual results — FY 2025 Revenue USD 257.5M · Net USD -48.8M
    2024-11-07 16:38 UTCEARNINGSQuarterly results — Q3 2024 Revenue USD 61.6M · Net USD -16.0M
    2024-08-07 16:16 UTCEARNINGSQuarterly results — Q2 2024 Revenue USD 64.6M · Net USD -1.9M
    2024-05-09 16:39 UTCEARNINGSQuarterly results — Q1 2024 Revenue USD 65.5M · Net USD -18.4M
    2024-03-13 16:05 UTCEARNINGSAnnual results — FY 2024 Revenue USD 269.4M · Net USD -65.1M
    2023-03-31 07:00 UTCEARNINGSAnnual results — FY 2023 Revenue USD 284.3M · Net USD -202.3M
    2022-03-24 07:00 UTCEARNINGSAnnual results — FY 2022 Revenue USD 209.3M · Net USD 20.3M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage